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Abstract 
We characterized a mitochondrial DNA deletion in a patient with Kearns-Sayre syndrome. Southern blot hybridization showed that 86 
to 93% of the mitochondrial genome harbored a 5.0 kb deletion. The percentage of affected genomes is higher than in previously 
described cases. Direct sequencing of the breakpoint region revealed that the deletion extended 5025 bp from nt l0 050 in the tRNA Gly 
gene to nt 15 076 in the cytochrome b gene, thus 30% of the total mitochondrial genome was lost by this deletion. A pair of extremely 
short mirror sequences flanking the mitochondrial DNA breakpoints were identified. These flanking sequences differ from previously 
published consensus 'hot-spots', known to give rise to deletions in human mitochondrial DNA. 
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Human mitochondrial DNA (mtDNA) is a small, circu- 
lar, double stranded molecule of 16.6 kilobases [1,2]. 
Three clinical presentations, Kearns-Sayre syndrome 
(KSS), Chronic Progressive External Ophthalmoplegia 
(CPEO) and Pearson's pancreas-bone marrow syndrome, 
have been associated with deleted mtDNAs in muscle and 
other tissues [3-5]. KSS is a sporadic disorder that appears 
before the age 20, with pigmentary retinopathy, progres- 
sive external ophthalmoplegia, plus complete heart block, 
elevated cerebrospinal fluid proteins, and cerebellar syn- 
drome [6]. KSS patients exhibit deletions of muscle mtDNA 
[7-9]. We found an unusually high abnormal mtDNA 
population harboring a 5025 bp deletion that differed from 
the so called 'common deletion' in a patient with KSS. 
Two short mirror sequences AAAGA and AGAAA, differ- 
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ent from the previously observed 'hot spots' [10-13], were 
found to flank the mtDNA breakpoint. 
Case summary. A 17-year-old male was the third of 
four siblings. At the age of four, he showed psychomotor 
delay. During the next ten years learning disability led to 
scholar failure. Ptosis and external ophthalmoplegia was 
detected at the age of twelve. At thirteen he started having 
syncopal episodes, and at sixteen he received a cardiac 
pacemaker. One year later KSS was diagnosed, based on 
the criteria of Rowland et al. [6]. On examination, the 
patient had short stature, microcepha!y (52 cm), bradylalia, 
bradypsychia and bradyphrenia, complete xternal ophthal- 
moplegia, optic fundi with bilateral retinitis, spastic 
quadriplegia predominant on the right side, choreic move- 
ments on both arms, and bilateral cerebellar syndrome. 
Protein in the cerebrospinal fluid was elevated to 72 
mg/ml  (normal evels are 15-45 mg/ml).  Serum levels of 
lactic acid were increased to 49.3 mg/dl  (normal values of 
5.7 + 2.2 mg/dl). Computerized tomography demon- 
strated diffuse cerebral atrophy and a slight parenchymal 
left parietal hemorrhagic nfarct. 
Muscle biopsy and pathological analysis. Quadriceps 
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muscle biopsy was performed under local anesthesia nd 
immediately frozen in liquid nitrogen. Cryostat sections 
were stained with HE, Gomori-modified trichrome, and 
NADH dehydrogenase. A fragment was fixed in glu- 
taraldehyde, postfixed in 1% OsO 4 and embedded in Epon 
for ultrastructural studies. 
Recombinant DNA techniques. Total DNA was isolated 
from frozen muscle biopsies following the method of 
Davis et al. [14] with the modifications of Zeviani et al. 
[9]. DNA was digested with PvuII, electrophoresed through 
a 0.8% agarose gel, transferred to a nylon membrane as 
described by Sambrook et al. [15] and probed with a 
biotin-labelled fragment of normal mtDNA comprising 
nucleotides 126-1776. Quantitation was carried out in an 
UltroScan XL densitometer (LKB) using the program 
GelScan XL. Restriction endonuclease mapping was done 
as described by Zeviani et al. [9] with the restriction 
enzymes PstI, KpnI, XbaI, HindIII, EcoRI, and StuI. 
PCR amplification and sequencing. The following de- 
oxyoligonucleotides (synthesized by Operon Technologies) 
were used as amplification primers: 140F-Hind (nt 126-150 
complementary to the H strand); 1768B-Hha (nt 1754-1776 
complementary to the L strand); 7973F-Bst (nt 7955-7979 
complementary to the H strand); 9910F-Asu (nt 9902-9923 
complementary to the H strand); and 16048B-Kpn (nt 
16 033-16 060 complementary to the L strand). Two addi- 
tional primers were synthesized by Dr. L. Ongay (UNAM, 
Mexico): COX3F (nt 9270-9300 complementary to the H 
strand) and NAD4B (nt 10820-10850 complementary to 
the L strand). Total DNA from the muscle biopsy was used 
as template for amplification by PCR (polymerase chain 
reaction). Reaction mixtures were denatured at 94 ° C for 
10 rain, followed by 25 cycles of 1 min denaturation at 
94 ° C, 2 min annealing at 60°C and 2 min extension at 
72 ° C. PCR products were gel-purified and ligated into the 
pCRII TM plasmid (Invitrogen). Standard recombinant DNA 
techniques were carried out essentially as described by 
Sambrook et al. [15], and nucleotide sequencing according 
to Sanger et al. [16]. 
Blue Native electrophoresis (BNE). Blue Native gels 
and second dimension analysis were carried out as de- 
scribed by Schiigger and von Jagow [17], starting from 40 
mg (wet weight) of muscle biopsy and using 1% lauryl 
maltoside in the solubilization step. Protein concentrations 
were determined according to Lowry et al. [18] with the 
modifications of Markwell et al. [19]. 
Pathological analysis. Histochemical analysis of the 
muscle biopsy stained with the Gomori-modified trichrome 
showed the presence of numerous ragged-red fibers and 
muscle fibers with increased enzymatic activity for NADH. 
Electron microscopy revealed severe abnormalities in the 
size and shape of mitochondria, with globular and geomet- 
ric inclusions (data supplied to reviewers but not shown). 
Biochemical analysis. BNE is especially useful for small 
scale purposes, such as the visualization of the respiratory 
complexes from muscle biopsies [17]. The mitochondrial 
fraction from the patient's biopsy was small and adhered 
to the walls of the centrifuge tube. The same protein 
quantities of both mitochondrial fractions were solubilized 
with the non-ionic detergent lauryl maltoside and subjected 
to BNE. Fig. 1 shows the first and second-dimension gels 
of the silver stained Blue Native gels obtained for mito- 
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Fig. 1. Silver stained Blue Native gel for the resolution of fully-assembled mitochondrial membrane complexes. Two-dimensional resolution of 
mitochondria from the normal muscle sample (A) and from the KSS patient biopsy (B). BNE was run in the first dimension (horizontal lanes) loading 300 
p~g of protein. A Sch~igger et al. [17] gel system (16% acrylamide) was used in the vertical dimension. 
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chondria from control muscle and the KSS patient. The 
absence of the complexes that participate in oxidative 
phosphorylation was evident in the patient's ample. Sec- 
ond dimension gels stained with silver nitrate confirmed 
that in the patient's ample, the amount of fully-assembled 
complexes was below detection level. 
Mitochondrial DNA deletion mapping and deletion- 
breakpoint sequencing. To explore the molecular basis of 
the disease, mtDNA from the patient and from normal 
muscle were analyzed by Southern blot hybridization using 
as probe a PCR-amplified and biotinylated fragment of 
normal mtDNA comprising nucleotides 126-1776. The 
hybridization analysis showed the presence of the full- 
length mitochondrial genome (16.6 kb) in the patient's 
sample and in the control. In addition, the patient's ample 
exhibited a population of smaller mtDNAs (11.6 kb) har- 
boring a 5.0 kb deletion (Fig. 2). The relative number of 
deleted mitochondrial genomes in the patient was quanti- 
fied by laser scanning densitometry and estimated to be 
between 86 and 93% (Fig. 3). 
As shown by Southern analysis, the deletion was flanked 
by a PstI site at nucleotide 9020 and by a KpnI site at 
position 16129. In the patient's mitochondrial genome the 
following restriction sites were absent: XbaI 10257, 
HindlII 11 680, HindlII 12570, EcoRI 12640, StuI 12980, 
StuI 13 958 and StuI 15048 (data supplied for review but 
not shown). To determine the exact breakpoint of the 
mtDNA deletion, direct sequence analysis was performed. 
The junction fragment was amplified from nt 9902 to nt 
16060 using the amplification primers 9910F-Asu and 
16048B-Kpn, giving rise to a product of 1.1 kb; this 
product was gel-purified, cloned and subjected to sequence 
analysis. Single-stranded DNA sequencing identified the 
breakpoints as adenine at nt 10050 and adenine at nt 
15076 (Fig. 4). The breakpoint joined the final region of 
the glycine tRNA gene with the gene of cytochrome b (cyt 
b). 
Two boxes with the mirror sequences AAAGA and 
AGAAA were identified at the starting point and at the 
end of the deletion (Fig. 4). To ascertain the presence of an 
intact AAAGA box in the original mtDNA, the 16.6 kb 
normal mitochondrial genome of the patient was also 
explored. The mtDNA was PCR-amplified from nt 9270 to 
nt 10850 using the primers COX3F and NAD4F. Direct 
nucleotide sequencing confirmed the presence of an unal- 
tered glycine tRNA gene in the region of the AAAGA 
sequence, identical to the one reported by Anderson et al. 
[1 ] (data not shown). This result suggested that no duplica- 
tion or additional mutations existed in the 16.6 kb mt DNA 
region. 
Biochemical characterization. BNE proved useful in the 
visualization of the mitochondrial respiratory complexes in 
a single gel starting from small amounts of muscle biop- 
sies obtained from healthy tissue [17]. Failure to observe 
the presence of these complexes in the KSS patient mito- 
chondrial fraction suggests the presence of very small 
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Fig. 2. Autoradiograph of a Southern blot of total DNA from a control 
subject (C) and the KSS patient (P). 5/zg of total DNA was digested with 
Pt,ulI, electrophoresed through a 0.8% agarose gel, transferred to nitro- 
cellulose, and probed with labelled DNA. Tile probe was a PCR-ampli- 
fled and biotinylated segment of normal mtDNA counprising nucleotides 
126-1776. Two populations of DNA are evident in the KSS patient, one 
corresponding to full-length mtDNA molecuh,~s (t6.6 kb) and the other to 
smaller mtDNAs ( 11.6 kb). 
amounts of fully-assembled complexes, i.e., below the 
detection level of silver staining. Alternatively, the mito- 
chondrial fraction of the patient may have been poorly 
solubilized by lauryl maltoside as compared with the frac- 
tion obtained from normal tissue. I11 any case, BNE pro- 
vides additional evidence of a clearly abnormal mitochon- 
drial population in the patient's muscular tissue. 
Mitochondrial DNA characterization. The data obtained 
in the present work are in accordance with the suggestion 
that most patients fulfilling the clinical and morphological 
criteria of Kearns-Sayre syndrome will have deletions in 
mtDNA [9]. The 5.0 kb deletion in the muscle mtDNA 
observed in this patient does not appear to be familial, 
since parents and siblings do not express symptoms of 
KSS. The deletion probably arose during the patient's 
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Fig. 3. Quantitation of normal and deleted mtDNAs in the KSS patient. 
The relative proportion of hybridizing signal from the full-length and 
deleted molecules were estimated by laser scanning densitometry of the 
autoradiography plate shown in Fig. 2. The relative number of mutated 
genomes (11.6 kb) was found to be between 86 and 93%. 
somatic development. The spontaneous nature of KSS is in 
accordance with the report of lack of transmission of 
deleted mtDNA from a woman with KSS to her child [20]. 
In the case we describe, 86 to 93% of the mitochondrial 
genomes had experienced DNA deletion. This is higher 
than in previously reported cases, where the relative pro- 
portion ranged from 27 to 85% [7,9]. In the abnormal 
mitochondrial genome described here, 11.8% of the tRNA 
for glycine was deleted, as well as the gene ND3, the 
tRNA for Arg, the genes ND4L and ND4, the tRNA for 
His, the tRNA for Ser (AGY), the genes ND5 and ND6, 
the tRNA for Glu, and 28.9% of the gene encoding cyt b. 
Approximately one third of the deletions described for 
KSS seem to be identical, extending over 4.9 kb within the 
region 8470-13 460 base pairs. The deletion junction has 
been sequenced and found to be bridged by direct repeats 
within the regions 8470-8482 in the ATPase 8 gene and 
13447-13459 in the NAD5 gene [13]. This kind of dele- 
tion is known as the 'common deletion', due to the fre- 
quency with which it occurs. A second relatively common 
deletion is associated with direct repeats in the regions 
8637-8648 (of the ATPase6 gene) and 16 073-16 085 (in 
the D-loop) [21]. Other deletions were also flanked by 
perfect direct repeats of 5-13 base pairs [ 13] and a consen- 
sus sequence was suggested to be involved in these recom- 
binational events [12]. In these deletions the exact break- 
point could not be determined as it could lie at either end 
of the repeat or within it. In the case we studied, the 
presence of two mirror 5 bp sequences allowed the precise 
determination of the breakpoint at nucleotide 10 050. The 
sequence AGAAA was at the beginning of the region that 
codes for cyt b, and the mirror sequence AAAGA at the 
start of the deleted section in the tRNA Gly gene. These 
extremely short mirror repeats differ from the direct re- 
peats found in other deletions in the mitochondrial DNAs 
of KSS patients [10-12]. 
Diseases associated with the presence of mtDNA dele- 
tions progress with age [22], apparently as consequence of
an augmented proportion of deleted genomes [23] which 
exhibit an increased rate of replication due to their shorter 
length [24]. These deletion mutants are functionally domi- 
nant over the wild-type mitochondrial genomes [25]. In the 
presently described KSS patient, the neurological disorder 
demonstrates dementia, ophthalmopathy, cerebellar signs, 
pyramidal and extrapyramidal findings and muscular disor- 
ders, with a clinical evolution of at least thirteen years, 
exhibiting mild neuropsychological disorders for some 
years before a multisystemic neurologic disease was evi- 
dent. Therefore, we hypothesize that during the life of the 
patient, mitochondrial function deteriorated progressively, 
and that this paralleled clinical evolution up to the appear- 
ance of a systemic disease with severe neurologic disfunc- 
tion. In fact, according to the threshold effect hypothesis, a 
certain level of abnormal mtDNA must be reached before 
systemic disfunction becomes apparent [22]. Recently, 
Hayashi et al. [26] showed that the introduction of deleted 
mitochondrial genomes into HeLa cells lacking mtDNA 
(cybrids) gives rise to mitochondrial disfunction character- 
istic of CPEO. Interestingly, when the levels of deleted- 
mtDNA exceeds 60% of the total population, mitochon- 
4. . . . . . . . . . . . . . . . . . . .  5,025 bp . . . . . . . . . . . . . . . .  -* 
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Fig. 4. DNA sequences (reading 5' to 3' on the L-strand) in the region of the deletion. The DNA sequence found in the deleted genome is on the lower 
line, with the intervening deleted DNA shown in the upper line (bracket). 
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drial translation may become limiting, resulting in progres- 
sive inhibition of overall mitochondrial translation and 
cytochrome c oxidase activity. This is believed to be due 
to the ability of the mutants to 'starve' the wild type of 
some essential components such as tRNAs. 
A slipped mispairing during replication of the mtDNA 
could be the mutagenic event that occurred during the 
somatic development of this patient. Slipped mispairing 
between distant repeats, originally proposed by Farabaugh 
et al. [27] for Escher ichia cola has been suggested to be 
responsible for larger-scale mitochondrial deletions associ- 
ated with neuromuscular disorders in humans [1 1,28-30]. 
Experimental evidence for the occurrence of slipped mis- 
pairing in mammalian mitochondria in vivo and in vitro 
has been recently provided [31]. The presence of two 
extremely short direct repeats flanking the deletion in the 
abnormal mitochondrial genome described here, may sug- 
gest a slipped mispairing mechanism during the replication 
of the mtDNA, in accordance to Shoffner et al. [11]. 
Following their model, as the heavy strand of mtDNA is 
displaced uring replication, the downstream 3'-TCTTT-5' 
(cyt b gene) sequence in the parental heavy strand (com- 
plementary to the 5'-AGAAA-3' box) could have base 
paired with the upstream light-strand 5'-AAAGA-3' (Gly 
tRNA gene) sequence xposed by the replicating fork. This 
hypothetical slip-replication mechanism explains the gen- 
eration of a normal mtDNA from the original parent light 
strand and a deleted mtDNA from the slip-replicated heavy 
strand. Interestingly, very short repeated sequences (of 5 
nucleotides with 4 matches), and even the absence of a 
repeated sequence, have been involved in the generation of 
large deletions in E. coli  [32]. 
In conclusion, our findings show that an extremely 
short sequence, showing an identity of only three residues 
out of five, seems to be involved in the generation of a 
relatively large mitochondrial DNA deletion in the mt 
genome of this KSS patient. Nevertheless, the presence of 
mirror repeats in the deletion described here, could also 
suggest a mechanism for the generation of mitochondrial 
deletions, alternative to the slip-replication mechanism, 
that remains yet to be elucidated. 
The authors wish to thank Drs. S. DiMauro and S. 
Shanske (Columbia University) for their help and sugges- 
tions all along the work. We also thank the encouragement 
given by Drs. A. Vel~.zquez and J.E. San Esteban in 
starting and pursuing this project. Stimulating discussions 
with Drs. C. Grmez-Eichelman a d C. Gdmez-Lojero are 
gratefully acknowledged. We are grateful for the excellent 
technical assistance of Dr. L. Ongay (I.F.C., UNAM) and 
the kind help of Dr. F. Santorelli in showing us many of 
the techniques used in this work. We are grateful to G. 
Ramfrez for typing the final version of the article and to 
Drs. S. DiMauro, S. Shanske, A. Grmez-Puyou, D.W. 
Krogmann, M. Gavilanes, E. Schon, and C. Grmez-Lojero 
for critical review of the original version of the manuscript. 
Special thanks are given to Dr. A. Grmez-Puyou, for his 
suggestions to the final version. This work was supported 
by a grant from the Programa Universitario de Investigacidn 
en Salud (P.U.I.S.) UNAM. 
References 
[I] Anderson, S., Bankier, A.T., Barrell, B.G., De Bruijn, M.H.L., 
Coulson, A.R., Drouin, J., Eperson, I.C.. Nierlich, D.P., Roe, B.A., 
Sanger, F., Schreier, P.H., Smith, P.H., Staden, R. and Young, I.G. 
( 1981 ) Nature (London) 290, 457-465. 
[2] Mariottini, P., Chomyn, A., Riley, M.. Cottrell, B., Doolittle, R.F. 
and Attardi, G. (1986) Proc. Natl. Acad. Sci. USA 83, 1563-1567. 
[3] Zeviani, M. and DiDonato, S. (1991) Neuromuscul. Disord. 1, 
165-172. 
[4] DiMauro, S. and Moraes, C.T. (1993) Ar,:h. Neurol. 50, 1197-1208. 
[5] Brown, M.D. and Wallace, D.C. (1994)J. Bioenerg. Biomembr. 26, 
273-289. 
[6] Rowland, L.P., Blake, D. and Hirano, M. (1991)Rev. Neurol. 147, 
467-473. 
[7] Moraes, C.T., DiMauro. S., Zeviani, M. Lombes, A., Shanske, S., 
Miranda, A.F., Nakase, H., Bonilla, E., Werneck, L.C., Servidei, S., 
Nonaka, I., Koga, Y., Spiro, A.J.. Brownell, K.W., Schmidt, B., 
Schotland, D.L., Zupanc, M., DeVivo, D.C., Schon, E.A. and Row- 
land, L.P. (1989) N. Engl. J. Med. 320, t293-1299. 
[8] Holt, I.J.. Harding, A.E. and Morgan-Hughes, J.A. (1988) Nature 
(London) 331, 717-719. 
[9] Zeviani, M., Moraes, C.T., DiMauro, S.. Nakase, M.D., Bonilla, E., 
Schon, E.A. and Rowland, L.P. (1988) IXeurology 38, 1339-1346. 
[10] Schon, E.A., Rizzuto. R.. Moraes, C.T., Nakase, H., Zeviani, M. and 
DiMauro, S. (1989) Science 244, 346-3z-9. 
[I 1] Shoffner. J M., Lott, M.T., Voljavec, A S., Soueidan, S.A., Costi- 
gan, D.A. and Wallace, D.C. (1989) Proc. Natl. Acad. Sci. USA 86, 
7952-7956. 
[12] Johns, D.R., Rutledge, S.L., Stine, O.C. and Hurko, O. (1989) Proc. 
Natl. Acad. Sci. USA 86, 8059-8062. 
[13] Mita, S., Rizzuto. R., Moraes, C.T., Shanske, S., Arnaudo, E., 
Fabrizi, G.M., Koga, Y., DiMauro, S. and Schon, E.A. (1990) 
Nucleic Acids Res. 18, 561-567. 
[14] Davis, L.G., Dibner, M.D. and Battey, J.F. (1986) Basic Methods in 
Molecular Biology, pp. 47-50, Elsevier, New York. 
[15] Sambrook. J., Fritsch. E.F. and Maniatis, T. (1989) Molecular 
Cloning, A Laboratory Manual, 2nd l-dn., Cold Spring Harbor 
Laboratory Press, Cold Spring Harbor. 
[16] Sanger, F., Nicklen. S. arid Coulson. A.R. (1977) Proc. Natl. Acad. 
Sci. USA 74, 5463-5467. 
[17] Schiigger, H. and Von Jagow, G. (19'-)1) Anal. Biochem. 199, 
223-231. 
[18] Lowry, O.H., Rosebrough, N.J.. Fan', A.I,. and Randall, R.J. (1951) 
J. Biol. Chem. 193. 265-275. 
[19] Markwell, M.A.K., Haas, S.M., Bieber. L.L. and Tolbert, N.E. 
(1978) Anal. Biochem. 87. 206-210. 
[20] Larsson, N.G., Eiken, H.G., Boman, H., ltolme, E., Oldfors. A. and 
Tulinius, M.H. (1992) Am. J. Hum. Genet. 50, 360-363. 
[21] Wallace, D.C. (1992) Annu. Rev. Biochem. 61, 1175-1212. 
[22] Larsson, N.G., Holme, E., Kristianson, B., Oldfors, A. and Tulinius, 
M.H. (1990) Pediatr. Res. 28, 131-136. 
[23] Wallace, D.C. (1989)Trends Genet. 5, 9--13. 
[24] Shoubridge, E.A., Karpati. G. and Hastin!,,s, K.E.M. (1990) Cell 62, 
43 -49. 
[25] Hayashi, J.1., Ohta, S., Kikuchi, A., Takemitsu, M., Goto, Y.I. and 
Nonaka, I. (1991) Proc. Natl. Acad. Sci. :'~8, 10614-10618. 
[26] Ozawa, T., Tanaka. M., Sugiyama, S., Hattori, K. and Ito, T. (1990) 
Biochem. Biophys. Res. Commun. 170, 830-836. 
368 M. V6zquez-Acevedo et al. / Biochimica et Biophysica Acta 1271 (1995) 363-368 
[27] Farabaugh, P.J., Schmeissner, U., Hofer, M. and Miller, J.H. (1978) 
J. Mol. Biol. 126, 847-857. 
[28] Dover, G.A. (1989) Trends Genet. 5, 100-102. 
[29] Zeviani, M., Bresolin, N., Gellera, C., Bordoni, A., Pannacci, M., 
Amati, P., Moggio, M., Servidei, S., Scarlato, G. and DiDonato, S. 
(1990) Am. J. Hum. Genet. 47, 904-914. 
[30] Degoul, F., Nelson, I., Amselem, S., Romero, N., Obermaier-Kusser, 
B., Ponsot, G., Marsac, C. and Lestienne, P. (1991) Nucleic Acids 
Res. 19, 493-496. 
[31] Madsen, C.S., Ghivizzani, S.C. and Hauswirth, W.W. (1993) Proc. 
Natl. Acad. Sci. USA 90, 7671-7675. 
[32] Albertini, A.M., Hofer, M., Calos, M.P. and Miller, J.H. (1982) Cell 
29, 319-328. 
